Novel three-pronged strategy to enhance cancer cell killing in glioblastoma cell lines: histone deacetylase inhibitor, chemotherapy, and oncolytic adenovirus dl520.
(Q46892005)
scientific article published in January 2006
scientific article published in January 2006
Language:
Current Data About
Novel three-pronged strategy to enhance cancer cell killing in glioblastoma cell lines: histone deacetylase inhibitor, chemotherapy, and oncolytic adenovirus dl520.
other details
description | scientific article published in January 2006 |
External Links
(P356) |
10.1089/HUM.2006.17.55
|
(P698) |
16409125
|